Ally Bridge MedAlpha Master Fund L.P. 13D and 13G filings for Cogent Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 4:17 pm Sale | 2021-12-31 | 13G | Cogent Biosciences, Inc. COGT | Ally Bridge MedAlpha Master Fund L.P. | 1,501,591 3.800% | -121,000 (-7.46%) | Filing |
| 2021-02-12 4:15 pm Purchase | 2020-12-31 | 13G | Cogent Biosciences, Inc. COGT | Ally Bridge MedAlpha Master Fund L.P. | 1,622,591 5.100% | 1,622,591 (New Position) | Filing |